Literature DB >> 28956093

Understanding cytokine release syndrome.

Philipp Gödel1, Alexander Shimabukuro-Vornhagen1, Michael von Bergwelt-Baildon2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28956093     DOI： 10.1007/s00134-017-4943-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  13 in total

1.  Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8).

Authors:  U Winkler; M Jensen; O Manzke; H Schulz; V Diehl; A Engert
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

2.  Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

Authors:  Julie C Fitzgerald; Scott L Weiss; Shannon L Maude; David M Barrett; Simon F Lacey; J Joseph Melenhorst; Pamela Shaw; Robert A Berg; Carl H June; David L Porter; Noelle V Frey; Stephan A Grupp; David T Teachey
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 3.  Severe cytokine release syndrome after the first dose of Brentuximab Vedotin in a patient with relapsed systemic anaplastic large cell lymphoma (sALCL): a case report and review of literature.

Authors:  Stefan K Alig; Martin Dreyling; Bettina Seppi; Benedikt Aulinger; Lukas Witkowski; Christina T Rieger
Journal:  Eur J Haematol       Date:  2014-07-02       Impact factor: 2.997

Review 4.  Immunotherapeutic implications of IL-6 blockade for cytokine storm.

Authors:  Toshio Tanaka; Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

Review 5.  CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.

Authors:  Jae H Park; Mark B Geyer; Renier J Brentjens
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

6.  Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.

Authors:  Marco L Davila; Isabelle Riviere; Xiuyan Wang; Shirley Bartido; Jae Park; Kevin Curran; Stephen S Chung; Jolanta Stefanski; Oriana Borquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsu Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana C G Bouhassira; Maria E Arcila; Mithat Gonen; Gail J Roboz; Peter Maslak; Dan Douer; Mark G Frattini; Sergio Giralt; Michel Sadelain; Renier Brentjens
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

Review 7.  Critical care of patients with cancer.

Authors:  Alexander Shimabukuro-Vornhagen; Boris Böll; Matthias Kochanek; Éli Azoulay; Michael S von Bergwelt-Baildon
Journal:  CA Cancer J Clin       Date:  2016-06-27       Impact factor: 508.702

8.  Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

Authors:  David T Teachey; Susan R Rheingold; Shannon L Maude; Gerhard Zugmaier; David M Barrett; Alix E Seif; Kim E Nichols; Erica K Suppa; Michael Kalos; Robert A Berg; Julie C Fitzgerald; Richard Aplenc; Lia Gore; Stephan A Grupp
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

9.  Current concepts in the diagnosis and management of cytokine release syndrome.

Authors:  Daniel W Lee; Rebecca Gardner; David L Porter; Chrystal U Louis; Nabil Ahmed; Michael Jensen; Stephan A Grupp; Crystal L Mackall
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113

Review 10.  Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells.

Authors:  Xiao-Jun Xu; Yong-Min Tang
Journal:  Cancer Lett       Date:  2013-10-16       Impact factor: 8.679
View more
  15 in total

1.  Intensivists in U.S. Acute Care Hospitals.

Authors:  Neil A Halpern; Kay See Tan; Meghan DeWitt; Stephen M Pastores
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

2.  Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression.

Authors:  Maureen L Drakes; Patrick J Stiff
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database.

Authors:  Alessandro Ceschi; Roberta Noseda; Karine Palin; Katia Verhamme
Journal:  Front Pharmacol       Date:  2020-05-04       Impact factor: 5.810

4.  Application Of Adoptive Immunotherapy In Ovarian Cancer.

Authors:  Siyu Yang; Xiaojiao Yin; Ying Yue; Siqing Wang
Journal:  Onco Targets Ther       Date:  2019-09-27       Impact factor: 4.147

5.  Multimodal Therapeutic Approach of Cytokine Release Syndrome Developing in a Child Given Chimeric Antigen Receptor-Modified T Cell Infusion.

Authors:  Gabriella Bottari; Pietro Merli; Isabella Guzzo; Francesca Stoppa; Annalisa Ruggeri; Matteo Di Nardo; Francesca Del Bufalo; Federica Galaverna; Cecchetti Corrado; Franco Locatelli
Journal:  Crit Care Explor       Date:  2020-01-29

Review 6.  Decoding inflammation, its causes, genomic responses, and emerging countermeasures.

Authors:  Jacek Hawiger; Jozef Zienkiewicz
Journal:  Scand J Immunol       Date:  2019-08-28       Impact factor: 3.487

7.  Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy.

Authors:  Hui Luo; Na Wang; Liang Huang; Xiaoxi Zhou; Jin Jin; Chunrei Li; Di Wang; Bin Xu; Jinhuan Xu; Lijun Jiang; Jue Wang; Yang Cao; Yi Xiao; Qian Zhang; Xia Mao; Songya Liu; Liting Chen; Min Xiao; Jianfeng Zhou
Journal:  J Immunother Cancer       Date:  2019-10-22       Impact factor: 13.751

Review 8.  Research advances in chimeric antigen receptor-modified T-cell therapy (Review).

Authors:  Yuxi Luo; Guiqin Song; Shichu Liang; Feifei Li; Kang Liu
Journal:  Exp Ther Med       Date:  2021-03-16       Impact factor: 2.447

Review 9.  The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.

Authors:  Dongfang Liu; Saiaditya Badeti; Gianpietro Dotti; Jie-Gen Jiang; He Wang; James Dermody; Patricia Soteropoulos; Deanna Streck; Raymond B Birge; Chen Liu
Journal:  Cell Commun Signal       Date:  2020-08-25       Impact factor: 5.712

10.  Dynamic chromatin regulatory landscape of human CAR T cell exhaustion.

Authors:  David G Gennert; Rachel C Lynn; Jeff M Granja; Evan W Weber; Maxwell R Mumbach; Yang Zhao; Zhana Duren; Elena Sotillo; William J Greenleaf; Wing H Wong; Ansuman T Satpathy; Crystal L Mackall; Howard Y Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.